This study will describe our institutional experience with facial nerve injury following cochlear implantation. We report the incidence, clinical presentation, course, and possible mechanisms of facial nerve paresis following implantation surgery and review the relevant literature.
Method: A retrospective chart review at a tertiary otologic referral center (teaching hospital) including all patients who underwent cochlear implant surgery between 2000 and 2010. Patients experiencing postoperative facial nerve weakness were identified, and data were gathered with respect to intraoperative findings, onset, severity, management strategy, and level of recovery.
Results: In the past decade, 815 implant surgeries were performed at our institution. All patients underwent a limited mastoidectomy with posterior tympanotomy (facial recess) approach, and intraoperative electromyographic facial nerve monitoring was routinely employed. No patients experienced immediate paresis while 5 implantees (0.6%) developed delayed onset weakness. All 5 patients were treated with steroid therapy, and all but one recovered to a House-Brackmann grade 1 (of 6) facial nerve function within 6 months of surgery.
Conclusion: The incidence of temporary facial nerve paresis following cochlear implantation at a tertiary teaching hospital was 0.49% while the incidence of permanent incomplete paralysis was 0.12%. Thermal injury and/or reactivation of latent virus with progressive neuroedema and subsequent delayed weakness are the most likely mechanisms of injury. Riccardo D'Eredita, MD (presenter) Objective: Assess stability of a new design titanium implant (Cochlear Baha BI300) in bone anchored hearing aid (Baha) recipients over time in a prospective, nonrandomized, onegroup study at a tertiary care institution.
Otology/Neurotology

The New Baha implant: A Prospective Osseointegration Study
Method:
Twelve patients who underwent one-stage Baha surgery over 4 months have been analyzed. Implant stability was measured with Implant Stability Quotient (ISQ) measurement tests. Patients were tested at surgery and every week after, for 1 year. Two-tailed Student test was calculated for all comparisons. P < .05 was considered significant.
Results:
The new implant showed a steep increase of ISQ values over the first 2 weeks and reached stable ISQ values 3 weeks after surgery. No significant difference on ISQ values was evident between children and adults. Complete healing time was obtained in 8 days on average (range, 7-12 days; median, 7.6). Neither implant extrusion nor skin revision surgery was observed in our patients during the first year of follow-up.
Conclusion:
In our hands this new implant revealed stability and fast integration. The data from the present study suggest the new implant may be suitable for early loading protocols.
Otology/Neurotology
Three-Week loading for Baha Bi-300 implant System Jack J. Wazen, MD (presenter); Benjamin Wycherly, MD; David S. Darley, MD; Seilesh Babu, MD; Julie Daugherty, RN Objective: Loading of titanium craniofacial implants is dependent upon osseointegration, the bonding of titanium oxide and bone. The purpose of this study seeks to determine the safety of early loading of the Baha BI-300 implant system (Cochlear Limited, Englewood, Colorado), which has been modified with novel surface texture and geometric design.
Method: This prospective multi-institutional study follows implant stability as determined by clinical evaluation and resonance frequency analysis (RFA) at implantation, 1, 3, 6, 12, and 24 weeks postopative, in 20 patients who underwent single-stage implantation and exteriorization of the BI-300. The processor was loaded at 3 weeks postoperative.
Results: Implant stability and the incidence of implant loss was compared with patients loaded at 6 weeks and the traditional 12 weeks postoperative. Our preliminary results confirm implant stability at 3 weeks postoperative. No increase in implant loss or postoperative complications were encountered as a result of the early loading.
Conclusion: Three-week loading of the BI-300 implant did not result in any failure of osseointegration. Earlier activation of the external processor with earlier hearing rehabilitation resulted in improved patient satisfaction. Method: OC explants were dissected from 3-day-old rat pups and cultured in (1) no treatment -control and (2) TNFa (2ug/ mL) for 96 hours in vitro for hair cell count studies and 24 and 48 hours in vitro for gene expression studies for GAPDH and Smac/Diablo genes.
Tumor Necrosis Factor Alpha Ototoxicity is Associated with Upregulation of Smac/Diablo Gene Expression in Rat Organ of Corti Explants
ORAL PRESENTATIONS
Results: There are statistically significant decreases in the numbers of viable inner and outer hair cells in TNFa-treated OC explants, when compared with the control group. Gene expression of pro-apoptotic Smac/Diablo is significantly increased at 48 hours in vitro (but not at 24 hours), when compared with controls. On-going studies are evaluating the expression of Smac/Diablo gene at 72 and 96 hours in vitro.
Conclusion:
The role of Smac/Diablo gene expression has not previously been studied in TNFa-challenged OC explants. These results suggest late up regulation of Smac/Diablo expression in TNFa ototoxicity, which may be important for the propagation of the apoptosis pathway in OC explants in vitro. (NIDCD RO1-05575) Method: Retrospective chart review looking at levels of hearing preservation after cochlear implantation in children and adults, using different electrode insertion techniques (N = 144 ears from 32 patients). Pre-and postoperative pure tone thresholds at 250, 500, and 1000 Hz frequencies were measured. Statistical analysis was performed using nonparametric method (Kruskal Wallis test).
Otology/Neurotology
Type of Electrode insertion and Hearing Preservation Outcomes
Results:
One hundred and four (72%) procedures were performed using standard cochleostomy, 25 (17 %) procedures were performed using soft surgery, and 15 (11 %) procedures were performed using round window insertion. Postoperative hearing thresholds were used as the main outcome measure. In all groups, residual hearing was preserved in different degrees (total: 30 %, moderate: 27 %, marginal: 37 %, none: 6 %). Statistically significant differences were encountered between the 3 groups. Soft surgery technique and round window insertion had better hearing preservation results compared to standard cochleostomy (P < .008 and P < .009, respectively). No difference between round window and soft surgery techniques was encountered (P = .07).
Conclusion:
Although cochlear implants are a revolutionary technology, they carry the risk of destroying residual hearing. Our study demonstrates that the use of soft surgery or round window techniques warrants better residual hearing when compared to standard cochleostomy.
Otology/Neurotology
Visualization of Endolyphatic Hydrops in Patients with Ménière's Disease by locally Enhanced inner Ear MRi: Correlation with Audiovestibular Function
Robert Gürkov, MD (presenter); Julia Louza; Michael Strupp; Wilhelm Flatz; Eike Krause, MD Objective: The pathophysiologic role of endolymphatic hydrops in Ménière's disease is still unresolved. The aim of this study was to determine whether the degree of endolymphatic hydrops as it is detected in vivo in patients with definite Ménière's disease correlates with audiovestibular function.
Method: In this prospective study, 37 patients with definite Ménière's disease were examined with intratympanic contrast enhanced temporal bone MRI. The degree of hydrops was then compared with hearing levels, SP/AP ratios, interaural amplitude ratios of vestibular evoked myogenic potentials and horizontal semicircular canal paresis.
Results: There was a significant correlation between the degree of hydrops on the one hand and the averaged hearing level at 0.25 to 1 kHz and 0.5 to 3 kHz (r = 0.71, P < .01) and the vestibular evoked myogenic potential interaural amplitude ratio (r = -0.44, P < .05) on the other hand. A trend toward a correlation was found between the hydrops and the caloric response; no correlation was found between the hydrops and the SP/AP ratio.
Conclusion:
The degree of endolymphatic hydrops correlates with a progressive loss of auditory and sacculus function in patients with Ménière's disease.
Otology/Neurotology
Water-Soluble Coenzyme Q10 in Chronic Hearing loss Luca Guastini, MD (presenter); Barbara Crippa; Francesco Mora, MD; Francesco-Antonio Salzano, MD; Renzo Mora, MD; Valentina Santomauro, MD Objective: Q-TER is a multicomposite water-soluble formulation of CoQ10; in particular, Q-TER consists of a mixture of maltodextrin, acting as a carrier, of CoQ10 molecules of sucrester, which serves as bioactivator. The purpose of this study was to evaluate the efficiency of Q-TER in subjects with chronic sensorineural hearing loss.
Method: A total of 80 patients affected by chronic sensorineural hearing loss were included. The patients were divided, at random, into 2 numerically equal groups (A and B). Group A underwent therapy with Q-TER, 160 mg, once a day for 30 days; group B received placebo, once a day for 30 days.
Results: Before, at the end, and 6 months after the end of the treatment, all patients underwent: pure tone audiometry, transient
